Thyroid最新文献

筛选
英文 中文
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease. 靶向芳基烃受体减弱甲状腺眼病中IGF1R信号
IF 5.8 1区 医学
Thyroid Pub Date : 2025-05-01 Epub Date: 2025-04-21 DOI: 10.1089/thy.2024.0529
Elisa Roztocil, Farha Husain, Charkira C Patrick, Steven E Feldon, Collynn F Woeller
{"title":"Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.","authors":"Elisa Roztocil, Farha Husain, Charkira C Patrick, Steven E Feldon, Collynn F Woeller","doi":"10.1089/thy.2024.0529","DOIUrl":"10.1089/thy.2024.0529","url":null,"abstract":"<p><p><b><i>Background:</i></b> Thyroid eye disease (TED) is an autoimmune disorder characterized by proptosis, inflammation, and fibrosis. Elevated insulin-like growth factor 1 receptor (IGF1R) signaling in TED orbital fibroblasts (OFs) drives the proliferation and biosynthesis of hyaluronan, which causes enlargement of orbital tissue volume. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that regulates cellular stress responses, metabolism, and inflammation. Given its important role in regulating cellular responses, we hypothesized that activation of the AHR could limit excessive IGF1R signaling in TED OFs, offering therapeutic potential. <b><i>Methods:</i></b> We measured IGF1R and AHR expression levels in TED, non-TED, and non-OF controls. OF activation was analyzed using proliferation, hyaluronan accumulation, and migration assays. RNA sequencing was used to detect transcriptome-wide changes in IGF1-treated TED OFs. After gene set enrichment analysis, select gene expression changes were validated by quantitative polymerase chain reaction. OFs were treated with the AHR ligands 6-formylindolo[3,2-b]carbazole (FICZ) or tapinarof with or without IGF1. Western blotting evaluated signaling pathways impacted by AHR and IGF1R signaling. <b><i>Results:</i></b> TED OFs showed elevated IGF1R and AHR expression levels compared to controls. IGF1 significantly increased hyaluronan accumulation, proliferation, and migration in TED OFs compared to non-TED OFs. IGF1R signaling altered the expression of hundreds of genes controlling cell migration, proliferation, and metabolism in TED OFs. These genes included <i>TUBA1B</i>, <i>TUBA1C</i>, <i>CRABP2</i> (upregulated), and <i>IRS2</i> and <i>SOD3</i> (downregulated). AHR activation blocked proliferation, migration, hyaluronan production, and gene expression mediated through IGF1R signaling. The AHR inhibited these pathways by reducing phosphorylation of GSK3β, an important mediator of IGF1R/β-catenin mediated signaling. <b><i>Conclusions:</i></b> AHR activation represents a promising therapeutic strategy for mitigating TED progression by inhibiting IGF1R signaling. Through modulation of GSK3β-mediated pathways, AHR activation may target additional pathologically relevant pathways beyond those affected by direct IGF1R inhibitors. This research provides novel insights into TED pathophysiology and offers a potential avenue for developing therapies to improve patient outcomes.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"527-542"},"PeriodicalIF":5.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residential Greenness Is Associated with Lower Thyroid Nodule Prevalence: A Nationwide Study in China. 居住环境绿化与低甲状腺结节患病率相关:中国一项全国性研究
IF 5.8 1区 医学
Thyroid Pub Date : 2025-05-01 Epub Date: 2025-04-23 DOI: 10.1089/thy.2024.0616
Siying Liu, Cihang Lu, Yongze Li, Lili Zhu, Zhongyan Shan, Weiping Teng, Tingting Liu
{"title":"Residential Greenness Is Associated with Lower Thyroid Nodule Prevalence: A Nationwide Study in China.","authors":"Siying Liu, Cihang Lu, Yongze Li, Lili Zhu, Zhongyan Shan, Weiping Teng, Tingting Liu","doi":"10.1089/thy.2024.0616","DOIUrl":"10.1089/thy.2024.0616","url":null,"abstract":"<p><p><b><i>Background:</i></b> The prevalence of thyroid nodules is increasing globally. This study explored the association between residential greenness and thyroid nodule prevalence. <b><i>Methods:</i></b> Data were collected from a national cross-sectional survey of 73,728 participants across 31 provinces in mainland China. Residential greenness was assessed with the normalized difference vegetation index (NDVI) and the enhanced vegetation index (EVI). Thyroid nodules >10 mm in diameter were diagnosed via ultrasound. We used quartile comparisons of the NDVI and EVI to compare nodule prevalence and employed logistic regression and restricted cubic spline analyses to examine nodules' associations with greenness. Interaction and sensitivity analyses were performed to test robustness. <b><i>Results:</i></b> A total of 73,728 participants were included in this study. The prevalence of 10 mm thyroid nodules decreased across NDVI500 quartiles: Q1: 7.99% (7.59-8.39%), Q2: 10.04% (9.60-10.48%), Q3: 6.59% (6.23-6.95%), and Q4: 5.20% (4.88-5.52%) (<i>p</i> for trend <0.001). The prevalence was 5.25% (95% confidence interval [CI]: 5.02-5.49%) in males and 9.09% (CI: 8.80-9.39%) in females. Logistic regression analysis showed that greater residential greenness was associated with a lower prevalence of thyroid nodules after adjusting for all covariates. This association was observed for both continuous greenness measures (NDVI500: odds ratio [OR] = 0.20, CI: 0.16-0.25; EVI500: OR = 0.08, CI: 0.06-0.12) and across quartiles (NDVI500 Q4: OR = 0.53, CI: 0.48-0.58; EVI500 Q4: OR = 0.55, CI: 0.51-0.60; both compared to Q1). Multiple sensitivity analyses confirmed this negative association, including the use of an alternative thyroid nodule definition (5 mm threshold), exclusion of individuals with cysts on ultrasound, and subgroup analyses excluding individuals with autoimmune thyroid antibody positivity, goiter, or both. In all these sensitivity analyses, NDVI and EVI data were assessed using both 500 m and 1000 m buffers. <b><i>Conclusion:</i></b> Our study is the first to identify an association between higher levels of residential greenness and a lower prevalence of thyroid nodules.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"543-552"},"PeriodicalIF":5.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144011383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is There a Better Way to Estimate Levothyroxine Doses for Hypothyroid Patients? 是否有更好的方法来估计甲状腺功能减退患者的左甲状腺素剂量?
IF 5.8 1区 医学
Thyroid Pub Date : 2025-05-01 Epub Date: 2025-04-14 DOI: 10.1089/thy.2025.0176
Mary H Samuels
{"title":"Is There a Better Way to Estimate Levothyroxine Doses for Hypothyroid Patients?","authors":"Mary H Samuels","doi":"10.1089/thy.2025.0176","DOIUrl":"10.1089/thy.2025.0176","url":null,"abstract":"","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"460-461"},"PeriodicalIF":5.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodality Ultrasound Utilizing Microvascular Flow Imaging and Shear Wave Elastography to Guide Fine-Needle Aspiration of Thyroid Lesions: A Prospective Study Validating Pattern-Based Microvascular Classification. 利用微血管血流成像和横波弹性成像的多模态超声引导细针穿刺甲状腺病变:一项基于模式的微血管分类的前瞻性研究。
IF 5.8 1区 医学
Thyroid Pub Date : 2025-05-01 Epub Date: 2025-04-21 DOI: 10.1089/thy.2024.0586
Jiamin Chen, Jing Zhong, Yu Zhuang, Bixue Deng, Jiayi Hong, Yuhong Lin, Zhongzhen Su, Xin Wen
{"title":"Multimodality Ultrasound Utilizing Microvascular Flow Imaging and Shear Wave Elastography to Guide Fine-Needle Aspiration of Thyroid Lesions: A Prospective Study Validating Pattern-Based Microvascular Classification.","authors":"Jiamin Chen, Jing Zhong, Yu Zhuang, Bixue Deng, Jiayi Hong, Yuhong Lin, Zhongzhen Su, Xin Wen","doi":"10.1089/thy.2024.0586","DOIUrl":"10.1089/thy.2024.0586","url":null,"abstract":"<p><p><b><i>Background:</i></b> Most current guidelines recommend fine-needle aspiration (FNA) biopsy of thyroid nodules based on grayscale ultrasound (GUS) features, but the biopsy rate for benign nodules remains high. Our aim was to construct a new pattern-based microvascular classification (PBMC) for thyroid nodules to develop and validate predictive multimodality US models based on GUS, microvascular flow imaging, and shear wave elastography, and compare FNA decision accuracy with the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS). <b><i>Methods:</i></b> This prospective study included consecutive patients with thyroid nodules who underwent multimodality US examinations from September 2022 to December 2023. Using PBMC, lesions were divided into three categories: malignant signs (convergence sign, piercing sign, and spoke wheel sign), benign signs (ring sign), and other vascular patterns. Univariate and multivariable logistic regression analyses were conducted to determine the odds ratios (ORs) of US features, including vascular signs, and construct predictive models based on multimodality US. Multimodality US models were validated with internal cross-validation and evaluated based on discrimination, calibration, and decision curve analyses. <b><i>Results:</i></b> Overall, 793 thyroid nodules confirmed using pathological analysis (248 benign and 545 malignant) in 599 participants (mean age, 43 years ±11 [SD]) were included. In univariate logistic regression analyses, malignant vascular signs showed a positive association with malignant nodules (OR: 10.43, 95% confidence interval [CI]: 5.76, 18.88; <i>p</i> < 0.01), whereas benign vascular signs were inversely associated with malignancy (OR: 0.10, 95% CI: 0.06, 0.16; <i>p</i> < 0.01). Four multivariable models incorporated GUS features, Young's modulus, and PBMC. The highest area under the receiver operating characteristic curve (AUC) was 0.95 (95% CI: 0.82, 0.97) for the multimodality US model, and the lowest AUC was 0.62 (95% CI: 0.57, 0.66) for ACR TI-RADS based on GUS (<i>p</i> < 0.001). At a 71% risk threshold, multimodality US avoided 27% (95% CI: 21, 34) of FNA procedures, compared with 13% (95% CI: 0, 38) with TI-RADS (<i>p</i> < 0.001). <b><i>Conclusion:</i></b> Visual assessment of microvascular morphology patterns may improve differentiation of benign and malignant thyroid nodules and potentially reduce the risk of unnecessary biopsy of benign thyroid nodules.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"516-526"},"PeriodicalIF":5.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144039082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining Ultrasound Imaging and Molecular Testing in a Multimodal Deep Learning Model for Risk Stratification of Indeterminate Thyroid Nodules. 结合超声成像和分子检测的多模态深度学习模型对不确定甲状腺结节的风险分层。
IF 5.8 1区 医学
Thyroid Pub Date : 2025-05-01 Epub Date: 2025-04-21 DOI: 10.1089/thy.2024.0584
Shreeram Athreya, Andrew Melehy, Sujit Silas Armstrong Suthahar, Vedrana Ivezić, Ashwath Radhachandran, Vivek R Sant, Chace Moleta, Henry Zheng, Maitraya Patel, Rinat Masamed, Masha Livhits, Michael Yeh, Corey W Arnold, William Speier
{"title":"Combining Ultrasound Imaging and Molecular Testing in a Multimodal Deep Learning Model for Risk Stratification of Indeterminate Thyroid Nodules.","authors":"Shreeram Athreya, Andrew Melehy, Sujit Silas Armstrong Suthahar, Vedrana Ivezić, Ashwath Radhachandran, Vivek R Sant, Chace Moleta, Henry Zheng, Maitraya Patel, Rinat Masamed, Masha Livhits, Michael Yeh, Corey W Arnold, William Speier","doi":"10.1089/thy.2024.0584","DOIUrl":"10.1089/thy.2024.0584","url":null,"abstract":"<p><p><b><i>Objective:</i></b> Indeterminate cytology (Bethesda III and IV) represents 15-30% of biopsied thyroid nodules and require additional diagnostic testing. Molecular testing (MT) is a commonly used diagnostic tool that evaluatesmalignancy risk through next generation sequencing of fine needle aspiration (FNA) samples. While MT achieves high sensitivity (97-100%) in ruling out malignancy, its specificity and positive predictive value (PPV) remain relatively low. This study proposes a multimodal deep learning model that integrates ultrasound (US) imaging with MT to improve risk stratification by enhancing PPV while maintaining high sensitivity. Combining these modalities leverages complementary information from both molecular and imaging data, addressing limitations in current approaches and offering a robust framework for evaluating indeterminate nodules. <b><i>Methods:</i></b> We retrospectively analyzed 333 patients with indeterminate thyroid nodules (259 benign, 74 malignant) at UCLA Medical Center between 2016 and 2022. We evaluated four configurations: whole frame US images, 256 × 256 patches, 128 × 128 patches, and an ensemble model combining the first three configurations. The clinical baseline consisted of Bethesda cytology and MT results. Models were assessed using five fold cross validation stratified by surgical outcomes. <b><i>Results:</i></b> The clinical baseline (Bethesda + MT) achieved an AUROC of 0.728 [0.68, 0.78] with sensitivity of 0.946 [0.88, 1.00], specificity of 0.664 [0.60, 0.73], and PPV of 0.448 [0.41, 0.48]. The proposed ensemble model demonstrated improved performance, achieving an AUROC of 0.831 [0.77, 0.89] with a sensitivity of 0.946 [0.88, 1.00], specificity of 0.703 [0.66, 0.75], and PPV of 0.477 [0.46, 0.50]. These improvements were statistically significant (<i>p</i> = 0.0008). <b><i>Conclusion:</i></b> Our multimodal model enhances MT performance by providing statistically significant improvements in PPV and specificity while maintaining high sensitivity. Our framework could be leveraged to reduce the number of benign thyroid resections in patients with indeterminate nodules. However, this study is limited by its single center dataset, lack of external validation, and the use of binarized MT outputs rather than granular malignancy risk probabilities. Future work should validate these findings across diverse populations and larger external datasets for more comprehensive risk stratification.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"590-594"},"PeriodicalIF":5.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144045016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Thyroid Function Test Abnormalities During Pregnancy: A Systematic Review of the Literature to Validate Current Risk Factors and Identify Novel Ones. 妊娠期间甲状腺功能检查异常的危险因素:一项系统的文献综述,以验证当前的危险因素和识别新的危险因素。
IF 5.8 1区 医学
Thyroid Pub Date : 2025-05-01 Epub Date: 2025-04-29 DOI: 10.1089/thy.2024.0743
Yindi Liu, Joris A J Osinga, Spyridoula Maraka, Sofie Bliddal, Erik K Alexander, Chrysoula Dosiou, Kristien Boelaert, Gabriela Brenta, Elise Krabbendam, Jennifer L Eaton, Haixia Guan, Sun Y Lee, Lilah F Morris-Wiseman, Caroline T Nguyen, Zhongyan Shan, Rima K Dhillon-Smith, Elizabeth N Pearce, Robin P Peeters, Angela M Leung, Tim I M Korevaar
{"title":"Risk Factors for Thyroid Function Test Abnormalities During Pregnancy: A Systematic Review of the Literature to Validate Current Risk Factors and Identify Novel Ones.","authors":"Yindi Liu, Joris A J Osinga, Spyridoula Maraka, Sofie Bliddal, Erik K Alexander, Chrysoula Dosiou, Kristien Boelaert, Gabriela Brenta, Elise Krabbendam, Jennifer L Eaton, Haixia Guan, Sun Y Lee, Lilah F Morris-Wiseman, Caroline T Nguyen, Zhongyan Shan, Rima K Dhillon-Smith, Elizabeth N Pearce, Robin P Peeters, Angela M Leung, Tim I M Korevaar","doi":"10.1089/thy.2024.0743","DOIUrl":"10.1089/thy.2024.0743","url":null,"abstract":"<p><p><b><i>Background:</i></b> International guidelines recommend that the indication to perform thyroid function testing during pregnancy is based on the presence of risk factors for thyroid function test abnormalities. However, the discriminative ability of currently recommended risk factors is questionable. To inform on an update of the American Thyroid Association Guidelines for the Diagnosis and Management of Thyroid Disease in Preconception, Pregnancy, and the Postpartum, we aimed to systematically review the literature to evaluate evidence for current risk factors and potential novel ones for thyroid function test abnormalities in pregnancy. <b><i>Methods:</i></b> A systematic literature search was performed on Embase, Medline Ovid, and the Cochrane Library from inception to October 17, 2024, to identify articles on the associations of any candidate variables with thyroid function test abnormalities, thyroid antibody positivity, or results of continuous thyroid function tests in pregnancy. Additional records were identified through citation searching. Study quality was assessed using the Newcastle-Ottawa Scale. We summarized the results using a narrative synthesis. <b><i>Results:</i></b> A total of 81 articles were included, describing 36 candidate variables. Thyroid antibody positivity was associated with a higher risk of overt or subclinical hypothyroidism compared with antibody negativity (absolute risks: 2.4-7.0% vs. 0.1-0.2% for overt hypothyroidism and 1.9-29.0% vs. 2.0-5.7% for subclinical hypothyroidism). In cases of iodine deficiency, sufficiency, and intake above pregnancy requirements or excess, the absolute risks for subclinical hypothyroidism were 2.2-42.6%, 1.42-16.0%, and 3.8-24.3%, respectively. A limited number of studies were available for history of autoimmune diseases, family history of thyroid disease, symptoms of hypothyroidism, and history of pregnancy loss, preterm delivery, or infertility. There was little or no association of current risk factors with isolated hypothyroxinemia or (subclinical) hyperthyroidism. We did not identify novel risk factors for thyroid function test abnormalities. <b><i>Conclusions:</i></b> Evidence for most currently recommended risk factors remains limited and heterogeneous, and no novel risk factor was identified. While risk factors can help guide thyroid function testing in pregnancy, a clinical risk assessment cannot be replaced. Future studies are needed to detect novel risk factors that can improve the accuracy and efficiency of identifying pregnant women at high risk of thyroid function test abnormalities, in particular, overt hypothyroidism.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"553-575"},"PeriodicalIF":5.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144049182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of Ultrasound Surveillance for Thyroid Cancer in Children. 儿童甲状腺癌超声监测的应用。
IF 5.8 1区 医学
Thyroid Pub Date : 2025-04-01 Epub Date: 2025-01-31 DOI: 10.1089/thy.2024.0624
Sanjay Rao, Mary C Frates, Carol B Benson, Christine E Cherella, Jessica R Smith, Ari J Wassner
{"title":"Utility of Ultrasound Surveillance for Thyroid Cancer in Children.","authors":"Sanjay Rao, Mary C Frates, Carol B Benson, Christine E Cherella, Jessica R Smith, Ari J Wassner","doi":"10.1089/thy.2024.0624","DOIUrl":"10.1089/thy.2024.0624","url":null,"abstract":"<p><p><b><i>Background:</i></b> Differentiated thyroid cancer (DTC) is the most common pediatric endocrine malignancy. The utility of ultrasound (US) surveillance after initial treatment has not been clearly delineated. We sought to evaluate the clinical utility of US for the detection of residual or recurrent disease in pediatric patients with thyroid cancer beginning 1 year after initial therapy. <b><i>Methods:</i></b> This is a retrospective cohort study of pediatric patients (<19 years) diagnosed with DTC between 1998 and 2022 whose response to therapy (RTT) one year after initial treatment (thyroidectomy ± radioactive iodine) was excellent or indeterminate. We evaluated the association between sonographic and biochemical findings (thyroglobulin [Tg] and Tg antibodies [TgAb]) at one year with the subsequent diagnosis of residual/recurrent structural disease in the neck (SDN). <b><i>Results:</i></b> In total, 112 patients had 1-year RTT that was excellent (<i>n</i> = 61, 54.5%) or indeterminate (<i>n</i> = 51, 45.5%). Median length of subsequent follow-up was 6.4 (interquartile range 3.8-8.9) years. Overall, 683 surveillance neck US were performed, with a mean ± standard deviation of 1.0 ± 0.4 US per patient per year. Of 61 patients with excellent RTT, none developed SDN during follow-up. Eighteen patients (29.5%) had a false-positive indeterminate or abnormal US finding. Of 51 patients with indeterminate RTT, 9 (17.6%) developed SDN during follow-up. SDN was detected by US in 7/9 cases (77.8%). SDN was detected by I-123 scan, but not by US, in two cases (22.2%), both with abnormal Tg/TgAb. 7/9 (77.8%) cases of SDN were detectable by Tg/TgAb. Overall, fine-needle aspiration (FNA) was performed in 17/112 (15.2%) patients and diagnosed SDN in six patients. Overall, 11/112 patients (9.8%) underwent FNA but were not diagnosed with SDN. <b><i>Conclusions:</i></b> In pediatric DTC patients with excellent response to initial therapy, the utility of serial US surveillance is limited by the low risk of SDN and frequent false-positive US findings. In children with indeterminate RTT, SDN occurs in a significant proportion and may be detected by US or by abnormal Tg/TgAb levels. These patients may benefit from the combination of US and biochemical surveillance.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"406-414"},"PeriodicalIF":5.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Maternal Thyroid Hormone Concentration with Normal Thyroid Function During Pregnancy and Preschoolers' Glycolipid Metabolism: A Birth Cohort Study. 孕期甲状腺功能正常的母亲甲状腺激素浓度与学龄前儿童糖脂代谢之间的关系:出生队列研究
IF 5.8 1区 医学
Thyroid Pub Date : 2025-04-01 Epub Date: 2025-03-07 DOI: 10.1089/thy.2024.0334
Wenjin Cai, Lu Chen, Manyu Zhang, Jiajun Ouyang, Penggui Wu, Juan Tong, Guopeng Gao, Shuangqin Yan, Fangbiao Tao, Kun Huang
{"title":"Association Between Maternal Thyroid Hormone Concentration with Normal Thyroid Function During Pregnancy and Preschoolers' Glycolipid Metabolism: A Birth Cohort Study.","authors":"Wenjin Cai, Lu Chen, Manyu Zhang, Jiajun Ouyang, Penggui Wu, Juan Tong, Guopeng Gao, Shuangqin Yan, Fangbiao Tao, Kun Huang","doi":"10.1089/thy.2024.0334","DOIUrl":"10.1089/thy.2024.0334","url":null,"abstract":"<p><p><b><i>Background:</i></b> Thyroid hormones (THs) are essential endocrine hormones that play key roles in individual's growth and development. There is limited knowledge about the association between maternal TH concentrations variations with normal thyroid function during pregnancy and offspring's glycolipid metabolism. <b><i>Methods:</i></b> A total of 1130 mother-child pairs from the Ma'anshan birth cohort were included in this prospective study. Maternal TH levels and thyroid peroxidase antibodies were measured in the 1st, 2nd, and 3rd trimesters of pregnancy during the childhood follow-up period. Fasting venous blood was collected from children at 4-6 years of age and glycolipid metabolic indicators were assayed. Analyses were performed using Binary logistic regression models, linear regression models, and Generalized linear regression model. <b><i>Results:</i></b> Maternal TH trajectories were fitted via latent category growth models. During the 1st trimester of pregnancy, maternal T3 and free thyroxine (fT4) levels were positively associated with children's blood glucose levels (β = 0.007 [CI 0.028-0.181]; β = 0.022 [CI 0.004-0.040]), whereas high levels of fT4 may be associated with decreased risk of children's hypercholesterolemia (OR = 0.870 [CI 0.768-0.986]). Maternal T4 concentrations during the 3rd trimester of pregnancy were negatively associated with children's cholesterol levels (β = -0.002 [CI -0.003-0.00]). High maternal TH levels were associated with high fasting glucose level and low low-density lipoprotein concentrations in children. <b><i>Conclusions:</i></b> Maternal TH dynamic variations may be associated with glycolipid metabolism in preschoolers, even when women do not have clinically diagnosed thyroid disorders. The exact associations between maternal THs in specific trimesters of pregnancy under normal thyroid function conditions and glycolipid metabolism in offspring require further investigation.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"444-456"},"PeriodicalIF":5.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143575991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Case-Control Study Examining the Association of Thyroid-Stimulating Hormone Suppression and Vascular Wall Inflammation on [18F]FDG-PET/CT. [18F]FDG-PET/CT检查促甲状腺激素抑制与血管壁炎症相关性的回顾性病例对照研究
IF 5.8 1区 医学
Thyroid Pub Date : 2025-04-01 Epub Date: 2025-03-07 DOI: 10.1089/thy.2024.0476
Holger Einspieler, Bengt Hennig, Bettina Reiterits, Hannah Klimpfinger, Marcus Hacker, Georgios Karanikas
{"title":"A Retrospective Case-Control Study Examining the Association of Thyroid-Stimulating Hormone Suppression and Vascular Wall Inflammation on [<sup>18</sup>F]FDG-PET/CT.","authors":"Holger Einspieler, Bengt Hennig, Bettina Reiterits, Hannah Klimpfinger, Marcus Hacker, Georgios Karanikas","doi":"10.1089/thy.2024.0476","DOIUrl":"10.1089/thy.2024.0476","url":null,"abstract":"<p><p><b><i>Background:</i></b> This retrospective case-control study aimed to investigate the effects of thyroid-stimulating hormone (TSH) suppression on vascular wall inflammation, assessed by [<sup>18</sup>F]-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). Vascular [<sup>18</sup>F]FDG-uptake is highly correlated with arterial inflammation, which represents a major risk factor for atherosclerotic plaques. <b><i>Methods:</i></b> Forty patients with differentiated thyroid cancer underwent [<sup>18</sup>F]FDG-PET/CTs under TSH suppression therapy following surgical removal of the thyroid and subsequent radioiodine ablation. The [<sup>18</sup>F]FDG-uptake was measured in the carotid arteries, aortic arch, and the ascending, descending, and abdominal aorta. All measurements in the PET scans were normalized to body weight and corrected for blood pool activity in the superior vena cava, creating target-to-background ratios (TBRs). Twenty-five patients with euthyroid hormone status were used as a control group. In addition, to evaluate long-term changes, the follow-up PET/CTs of 24 thyroid carcinoma patients under continued TSH suppression therapy were analyzed. <b><i>Results:</i></b> In patients with TSH suppression, significantly higher arterial [<sup>18</sup>F]FDG-uptake (<i>p</i> < 0.001) was observed in the ascending aorta, aortic arch, abdominal aorta, carotid artery, and for all arterial vessels combined (mean TBR<sub>max</sub> ± standard deviation [SD]: 1.8 ± 0.4, 1.8 ± 0.3, 1.9 ± 0.4, 1.4 ± 0.3, 1.7 ± 0.2, respectively) compared with the euthyroid control group (TBR<sub>max</sub> ± SD: 1.4 ± 0.2, 1.4 ± 0.2, 1.4 ± 0.2, 1.1 ± 0.2, 1.3 ± 0.1, respectively). In the subgroup of patients who received an additional follow-up scan after a mean duration of 1.9 ± 1.1 years of continued TSH suppression therapy, no significant changes in arterial [<sup>18</sup>F]FDG-uptake were found in the five arterial sites when both scans were compared over time (<i>p</i> > 0.05). <b><i>Conclusions:</i></b> Our study suggests that patients under TSH suppression may experience a significant increase in vascular [<sup>18</sup>F]FDG-uptake, a marker of arterial inflammation, and, therefore, might be at higher risk for cardiovascular disease. Interestingly, the duration of TSH suppression was not significantly associated with vascular [<sup>18</sup>F]FDG-uptake in our study, indicating that the observed increase in arterial inflammation may not be influenced by the duration of TSH suppression.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"357-366"},"PeriodicalIF":5.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-Infiltrating Lymphocytes Assessed Using the International TILs Working Group System Are Not Prognostic in Medullary Thyroid Cancer. 使用国际TILs工作组系统评估肿瘤浸润淋巴细胞不能预测甲状腺髓样癌的预后。
IF 5.8 1区 医学
Thyroid Pub Date : 2025-04-01 Epub Date: 2025-01-27 DOI: 10.1089/thy.2024.0595
Alexander Papachristos, Lydia Zhou, Amy Sheen, Mark Sywak, Bruce Robinson, Roderick Clifton-Bligh, Stan Sidhu, Anthony J Gill
{"title":"Tumor-Infiltrating Lymphocytes Assessed Using the International TILs Working Group System Are Not Prognostic in Medullary Thyroid Cancer.","authors":"Alexander Papachristos, Lydia Zhou, Amy Sheen, Mark Sywak, Bruce Robinson, Roderick Clifton-Bligh, Stan Sidhu, Anthony J Gill","doi":"10.1089/thy.2024.0595","DOIUrl":"10.1089/thy.2024.0595","url":null,"abstract":"<p><p><b><i>Background:</i></b> Tumor-infiltrating lymphocytes (TILs) are a protective prognostic factor in several solid tumors and predict response to immune checkpoint inhibitor therapy. The prognostic impact of TILs in medullary thyroid cancer (MTC) is poorly understood. <b><i>Materials and Methods:</i></b> In this retrospective cohort study, we assessed the TILs profile of primary MTC tumors using the International TILs Working Group system and correlated this with clinicopathological prognostic variables, including the International Medullary Thyroid Cancer Grading System (IMTCGS) grade and survival outcomes. <b><i>Results:</i></b> We identified 71 patients with primary MTC tumors who were treated surgically between 1995 and 2016 at the Royal North Shore Hospital in Sydney, Australia. The median (interquartile range) duration of follow-up was 69 (90) months. Using the ITWG system, all patients with MTC had low TILs, with a median (range) of 3% (0-10%). This group was further subdivided into \"very low\" (0-4%) and \"low\" (5-10%), and on Cox regression analysis, increasing TILs were associated with increased local recurrence (log-rank <i>p</i> = 0.022, odds ratio [OR] 1.94 [confidence interval or CI 0.61-6.16], <i>p</i> = 0.26), reduced disease-specific survival (log-rank <i>p</i> = 0.015, OR 5.11 [CI 1.01-26.0], <i>p</i> = 0.049), and a trend to decreased distant metastasis-free survival (log-rank <i>p</i> = 0.14). When examining the association between TILs and other prognostic factors, only \"high IMTCGS grade\" was significantly associated with increased TILs (OR 7.29 [CI 1.21-43.90], <i>p</i> = 0.015). In the multivariable logistic regression analysis, there was no significant association between TILs and local recurrence or disease-specific survival. <b><i>Conclusions:</i></b> In our study, the prognostic value of TILs in MTC was limited. Even high-grade MTC can be considered an immune quiescent tumor, and the adverse prognostic factors associated with higher grade tumors outweigh the marginal increase in immune recognition associated with a slight increase in TILs. The low level of TILs in MTC and their lack of correlation with survival suggest that immune checkpoint inhibitor therapy may not be effective.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"379-386"},"PeriodicalIF":5.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143047899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信